CathWorks
CathWorks develops the FFRangio® System, an AI-driven, drug-free, and wire-free technology for comprehensive physiologic assessment of coronary arteries, enhancing clinical decision-making and patient outcomes in cardiovascular care.
CathWorks develops the FFRangio® System, an AI-driven, drug-free, and wire-free technology for comprehensive physiologic assessment of coronary arteries, enhancing clinical decision-making and patient outcomes in cardiovascular care.